David Lebwohl, EVP, Chief Medical Officer at Intellia Therapeutics, Inc. (NTLA), sold 2,400 shares at $149.81 ($360K) on 2021-09-21, disclosed to the SEC on 2021-09-23.
Open-market sale of $360k NTLA by EVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2024-01-05 | $344K | — | Filing → |
| NTLA | SELL | 2023-01-06 | $192K | — | Filing → |
| NTLA | SELL | 2022-03-03 | $236K | — | Filing → |